Boston Scientific Corporation

0HOY.L | Healthcare | LSE
$98.86
+0.63 (+0.64%)

Key Metrics

Market Cap
$146.57B
P/E Ratio
186.53
EPS
$0.53
Beta
N/A
Dividend Yield
N/A
ROE
11.48%
Current Ratio
1.37

Company Information

Industry
Medical Equipment Services

About Boston Scientific Corporation

Boston Scientific Corporation develops manufactures and markets medical devices for use in various interventional medical specialties worldwide It operates through three segments MedSurg Rhythm and Neuro and Cardiovascular The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions devices to treat various urological and pelvic conditions implantable cardioverter and implantable cardiac resynchronization therapy defibrillators pacemakers and implantable cardiac resynchronization therapy pacemakers and remote patient management systems It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3D cardiac mapping and navigation solutions ablation catheters diagnostic catheters mapping catheters intracardiac ultrasound catheters delivery sheaths and other accessories spinal cord stimulator systems for the management of chronic pain indirect decompression systems and deep brain stimulation systems In addition the company offers interventional cardiology products including drugeluting coronary stent systems used in the treatment of coronary artery disease percutaneous coronary interventions products to treat atherosclerosis intravascular catheterdirected ultrasound imaging catheters fractional flow reserve devices and systems for use in coronary arteries and heart chambers as well as various peripheral vessels and structural heart therapies Further it provides stents balloon catheters wires and atherectomy systems to treat arterial diseases thrombectomy and acoustic pulse thrombolysis systems wires and stents to treat venous diseases and peripheral embolization devices radioactive microspheres ablation systems cryotherapy ablation systems and micro and drainage catheters to treat cancer The company was incorporated in 1979 and is headquartered in Marlborough Massachusetts

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-10-22 $0.75 $0.71 +5.0%
2025-07-23 $0.53 $0.73 -26.8%
2025-04-23 $0.45 $0.67 -32.9%
2025-02-05 $0.38 $0.66 -42.2%

Financial Ratios (TTM)

Gross Margin
63.23%
Operating Margin
16.77%
Net Margin
13.52%
ROA
6.02%
Price to Book
6.48
Price to Sales
7.87